

1. Phthaloyl Amlodipine
2. 88150-62-3
3. Phthaloylamlodipine
4. (+/-)-phthalimidoamlodipine
5. 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-((2-(1,3-dioxoisoindolin-2-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
6. 9qao5crp93
7. Amlodipine Related Compound D
8. Mfcd07782096
9. 3,5-pyridinedicarboxylic Acid, 4-(2-chlorophenyl)-2-((2-(1,3-dihydro-1,3-dioxo-2h-isoindol-2-yl)ethoxy)methyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester
10. 3-o-ethyl 5-o-methyl 4-(2-chlorophenyl)-2-[2-(1,3-dioxoisoindol-2-yl)ethoxymethyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
11. 3-ethyl 5-methyl (4rs)-4-(2-chlorophenyl)-2-((2-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
12. 4-(2-chloroethyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-((2-phthalimidoethoxy)methyl)-1,4-dihydropyridine
13. 4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-2-((2-phthalimidoethoxy)methyl)-1,4-dihydropyridine
14. 3-ethyl 5-methyl (4rs)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
15. Amlodipine Ep Impurity A
16. Unii-9qao5crp93
17. Amlodipine Besilate Impurity A
18. Chembl295696
19. Schembl3185862
20. Dtxsid30893841
21. Bcp13465
22. Amlodipine Besilate Impurity A [ep]
23. Akos015895609
24. Sb64137
25. 3,5-pyridinedicarboxylic Acid,4-(2-chlorophenyl)-2-[[2-(1,3-dihydro-1,3-dioxo-2h-isoindol-2-yl)ethoxy]methyl]-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester
26. Ac-19466
27. As-75270
28. Sy107510
29. Cs-0136897
30. Ft-0658434
31. P2406
32. Amlodipine Related Compound D [usp-rs]
33. Ec 413-410-3
34. F19238
35. 150p623
36. A842484
37. Amlodipine Besilate Impurity A [ep Impurity]
38. Q-201577
39. Q27272892
40. 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-(2-(1,3-dihydro-1,3-dioxo-(2h)isoindol-2-yl)-ethoxymethyl)-6-methyl-3,5-pyridinedicarboxylate
41. 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1,3-dioxo-2,3-dihydro-1h-isoindol-2-yl)ethoxy]methyl}-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
42. 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1.3-dioxo-1.3-dihydro-2h-isoindol-2-yl) Ethoxy] Methyl}-6-methyl-1.4-dihydro-3.5-pyridine Dicarboxylate
43. 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1.3-dioxo-1.3-dihydro-2h-isoindol-2-yl) Ethoxy]methyl}-6-methyl-1.4-dihydro-3.5-pyridine Dicarboxylate
44. 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-{[2-(1.3-dioxo-1.3-dihydro-2h-isoindol-2-yl)ethoxy]methyl}-6-methyl-1.4-dihydro-3.5-pyridine Dicarboxylate
45. 3-ethyl-5-methyl-4-(2-chlorophenyl)-2-((2-(1,3-dioxoisoindolin-2-yl)ethoxy)methyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
46. 4-(2-chlorophenyl)-2-methyl-6-[(2-phthalimidylethoxy)methyl]-1,4-dihydropyridine-3,5-dicarboxylic Acid 3-methyl 5-ethyl Ester
47. 4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-(2-phthalimidoethoxy)methyl-1,4-dihydropyridine
48. 4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-2-[2-phthalimidoethoxymethyl]-1,4-dihydropyridine
49. Phthaloyl Amlodipine; Amlodipine Usp Rc D; Phthalimido Amlodipine; 3-ethyl 5-methyl (4rs)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2h-isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
| Molecular Weight | 539.0 g/mol |
|---|---|
| Molecular Formula | C28H27ClN2O7 |
| XLogP3 | 4.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 11 |
| Exact Mass | 538.1506789 g/mol |
| Monoisotopic Mass | 538.1506789 g/mol |
| Topological Polar Surface Area | 111 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 999 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
BUILDING BLOCK
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
An integrated company with complete control of key starting materials, advanced intermediates & high-quality APIs.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
An integrated company with complete control of key starting materials, advanced intermediates & high-quality APIs.
MARKET PLACE